Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Indivior Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 34.21 · gapped above the open, then crossed back over prior close. High/low 34.64 at 7:00 am ET, 33.79 at 3:00 pm ET.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of INDV revenue | Skew |
|---|---|---|---|
| AQSTAquestive Therapeutics, Inc. | 73.00% | 2.62% | 28× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Indivior accounted for approximately 73% and 62% of our revenues for 2025 and 2024, respectively, and we believe in the future will continue to account for a substantial part of our revenues.”
$33M relationship28× more of AQST’s book than INDV’s
basisAQST fy2025 · closed 2025-12 $45MINDV fy2025 · closed 2025-12 $1.2B
FILING10-K0001398733-26-000018cik 0001398733disclosed by AQST
“License & research agreement with Indivior PLC On January 2, 2018, the Group entered into an agreement with Indivior for the discovery, development and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases.”
FILING20-F0001104659-26-062447cik 0001574232disclosed by ADXN
“Master Development and Supply Agreement effective the August 1, 2023 by and between Curia New Mexico, LLC and Indivior U.K. Limited”
FILING10-K0001628280-26-012237cik 0001625297
“Copacker Supply Agreement by and between Reckitt Benckiser Healthcare (U.K.) Limited and RB Pharmaceuticals Limited, dated December 23, 2014”
FILING10-K0001628280-26-012237cik 0001625297
“Master Packaging and Supply Agreement effective as of October 1, 2023 by and between Sharp Packaging Services, LLC, Indivior Inc., and Indivior U.K. Limited”
FILING10-K0001628280-26-012237cik 0001625297
Watchlist prices, news filtered to it, and its next report on your desk.
Indivior Pharmaceuticals, Inc. has 5 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Indivior Pharmaceuticals, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Indivior Pharmaceuticals, Inc.. Customers appear here when Indivior Pharmaceuticals, Inc. names them, or when a company names Indivior Pharmaceuticals, Inc. as a supplier in its own annual report.
INDV (Indivior Pharmaceuticals, Inc.) has 5 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ADXN −1.72%, in healthcare.